We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$719M
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$156M
AUM Growth
+$4.81M
(+3.2%)
Cap. Flow
+$5.92M
Cap. Flow
% of AUM
3.8%
Top 10 Holdings %
Top 10 Hldgs %
34.74%
Holding
105
New
16
Increased
44
Reduced
31
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.39M |
| 2 |
AbbVie
ABBV
|
+$1.41M |
| 3 |
AT&T
T
|
+$1.25M |
| 4 |
Vanguard Total Bond Market
BND
|
+$1.25M |
| 5 |
HCA Healthcare
HCA
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delta Air Lines
DAL
|
+$1.52M |
| 2 |
D.R. Horton
DHI
|
+$1.43M |
| 3 |
Apple
AAPL
|
+$1.25M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$1M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$958K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.52% |
| 2 | Communication Services | 12.91% |
| 3 | Financials | 12.32% |
| 4 | Healthcare | 10.94% |
| 5 | Technology | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
JetBlue
JBLU
$1.96B
| – | – |
-23,890
| Closed | -$505K |
|
102
LyondellBasell Industries
LYB
$19.5B
| – | – |
-4,445
| Closed | -$380K |
|
|
SEE
103
DELISTED
Sealed Air
SEE
| – | – |
-15,035
| Closed | -$722K |
|
104
Skyworks Solutions
SWKS
$9.06B
| – | – |
-6,231
| Closed | -$485K |
|
|
105
iShares TIPS Bond ETF
TIP
$14.5B
| – | – |
-8,718
| Closed | -$1M |
|
Similar funds
EI
SAM
KC
TFA
WRPWM
WLIM
NI
CFO
Fagan Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Fagan Associates held 105 positions worth $156M, up 3.2% from $151M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Fagan Associates deployed $5.92M of net new capital in Q2 2016, opening 16 new positions and adding to 44 existing holdings. Its largest new stake was Gilead Sciences: 38,165 shares worth $3.18M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 17% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was D.R. Horton, an estimated $1.43M trimmed.
- Fagan Associates's largest Q2 2016 buy was Gilead Sciences: 38,165 shares worth $3.18M.
- Fagan Associates added most to Vanguard Total Bond Market in Q2 2016, an estimated $1.25M increase.
- Fagan Associates's biggest Q2 2016 reduction was D.R. Horton, cutting an estimated $1.43M.
- Fagan Associates fully exited Delta Air Lines in Q2 2016, selling an estimated $1.52M.
- Fagan Associates's ten largest holdings make up 35% of its $156M portfolio in Q2 2016.
- Fagan Associates opened 16 new positions and closed 10 in Q2 2016.
- Fagan Associates's portfolio value rose 3.2% quarter-over-quarter to $156M.
Based on Fagan Associates's 13F filing for Q2 2016, filed 5 Aug 2016.